127 related articles for article (PubMed ID: 17851056)
21. [Topographic genomapping of p53 mutations in non-small cell lung cancer using in situ PCR].
Ebina M; Linnoila RI; Nukiwa T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):406-11. PubMed ID: 9063476
[TBL] [Abstract][Full Text] [Related]
22. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
23. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.
Horio Y; Takahashi T; Kuroishi T; Hibi K; Suyama M; Niimi T; Shimokata K; Yamakawa K; Nakamura Y; Ueda R
Cancer Res; 1993 Jan; 53(1):1-4. PubMed ID: 8380124
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of the Rb expression in adenocarcinoma of the lung.
Sugio K; Tsukamoto S; Ushijima C; Yamazaki K; Kase S; Yamaguchi M; Ondo K; Yano T; Sugimachi K
Anticancer Res; 2001; 21(3B):1931-5. PubMed ID: 11497280
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of lymph node micrometastases in human lung carcinoma: determination of p53 gene mutations by polymerase chain reaction-temperature gradient gel electrophoresis (PCR-TGGE)].
Xu ML; Wu BQ; Zhong HH; Yang X; Heng WJ
Ai Zheng; 2004 Jul; 23(7):794-8. PubMed ID: 15248914
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
Szymanowska A; Jassem E; Dziadziuszko R; Skrzypski M; Kobierska-Gulida G; Holm K; Borg A; Rzyman W; Limon J; Jassem J
Pneumonol Alergol Pol; 2005; 73(3):264-9. PubMed ID: 16989164
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
30. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
[TBL] [Abstract][Full Text] [Related]
31. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy].
Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133
[TBL] [Abstract][Full Text] [Related]
32. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
[TBL] [Abstract][Full Text] [Related]
33. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
[TBL] [Abstract][Full Text] [Related]
34. [The clinical significance of detection of p53 gene mutation in patients with lung cancer].
Chen Y; Cai Y; Liu L; Wang A; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Nov; 25(11):667-9. PubMed ID: 12490121
[TBL] [Abstract][Full Text] [Related]
35. [Study on the relationship between the polymorphism of p53 gene intron 7 and non-small cell lung cancer (NSCLC) and p53 mutation in NSCLC tissues].
Gu QH; Chen Q; Hu CP; Li YQ; Yang HZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):319-21. PubMed ID: 17557246
[TBL] [Abstract][Full Text] [Related]
36. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
37. [Genetic alteration of lung cancer as a prognostic marker and its therapeutic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():345-52. PubMed ID: 9369906
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer.
Yu M; Wan Y; Zou Q
Clin Biochem; 2008 Jul; 41(10-11):824-30. PubMed ID: 18420035
[TBL] [Abstract][Full Text] [Related]
39. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
Ran R; Cao XA; Tian Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
[TBL] [Abstract][Full Text] [Related]
40. [P53 and P16 gene mutations in non-small cell lung cancer].
Jassem E; Ramlau R; Dziadziuszko R; Szymanowska A; Jakóbkiewicz J; Lamperska K; Kobierska G; Skokowski J; Dyszkiewicz W; Mackiewicz A; Zylicz M; Jassem J
Pneumonol Alergol Pol; 2002; 70(1-2):64-70. PubMed ID: 12148179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]